Evidence map›Paper›PMID 34599919›Full record

Trial reportPreventive medicine2021

Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont.

Kelly R Peck, Nathaniel Moxley-Kelly, Gary J Badger, Stacey C Sigmon

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Preventive medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kelly R PeckThe Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: kelly.peck@uvm.edu.
Nathaniel Moxley-KellyThe Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: nathaniel.moxley-kelly@uvm.edu.
Gary J BadgerDepartment of Medical Biostatistics, University of Vermont, Burlington, VT, USA. Electronic address: gary.badger@uvm.edu.
Stacey C SigmonThe Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: stacey.sigmon@uvm.edu.

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KHADANGA, SHERRIE · 2013 to 2022
$21.3M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
Interim Buprenorphine Treatment to bridge waitlist delays: Stage II evaluationR01DA042790 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SIGMON, STACEY C · 2017 to 2021
$3.0M
NIDA NIH HHS R01 DA042790NIDA NIH HHS T32 DA007242NIGMS NIH HHS P20 GM103644
6 · The paper itself

Abstract

Posttraumatic stress disorder (PTSD) and opioid use disorder (OUD) may be associated with poor outcomes in rural areas where access to mental health services and opioid agonist treatment (OAT) is limited. This study examined the characteristics associated with a history of PTSD among a sample of individuals seeking buprenorphine treatment for OUD in Vermont, the second-most rural state in the US. Participants were 89 adults with OUD who participated in one of two ongoing randomized clinical trials examining the efficacy of an interim buprenorphine dosing protocol for reducing illicit opioid use during waitlist delays to OAT. Thirty-one percent of participants reported a history of PTSD. Those who did (PTSD+; n = 28) and did not (PTSD-; n = 61) report a history of PTSD were similar on sociodemographic and drug use characteristics. However, the PTSD+ group was less likely to have received prior OUD treatment compared to the PTSD- group (p = .02) despite being more likely to have a primary care physician (p = .009) and medical insurance (p = .002). PTSD+ individuals also reported greater mental health service utilization, more severe psychiatric, medical and drug use consequences, and greater pain severity and interference vs. PTSD- individuals (ps < 0.05). These findings indicate that a history of PTSD is prevalent and associated with worse outcomes among individuals seeking treatment for OUD in Vermont. Dissemination of screening measures and targeted interventions may help address the psychiatric and medical needs of rural individuals with OUD and a history of PTSD.

Indexed as

BuprenorphineOpioid-Related DisordersStress Disorders, Post-TraumaticAdultAnalgesics, OpioidHumansLongitudinal StudiesOpiate Substitution TreatmentVermontAnalgesics, OpioidBuprenorphineBuprenorphineInterim treatmentOpioid use disorderPosttraumatic stress disorderRurality

Identifiers

PMID34599919
PMCPMC8641000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.